Evidence map›Paper›PMID 39283489›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

Survival Dynamics in Advanced Ovarian Cancer: R2 Resection Versus No-Surgery Paths Explored.

Konstantinos Pitsikakis, Diederick DeJong, Konstantinos Kitsos-Kalyvianakis, Marios Evangelos Mamalis, Michela Quaranta, Aishath Shavee, Alina Wahab, Amudha Thangavelu, Timothy Broadhead, David Nugent and 2 more

Abstract read
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Konstantinos PitsikakisDepartment of Gynaecologic Oncology, ESGO Centre of Excellence for ovarian cancer surgery, St James's University Hospital, Leeds, UK.
Diederick DeJongDepartment of Gynaecologic Oncology, ESGO Centre of Excellence for ovarian cancer surgery, St James's University Hospital, Leeds, UK.ORCID 0000-0003-0081-674X
Konstantinos Kitsos-KalyvianakisDepartment of Gynaecologic Oncology, ESGO Centre of Excellence for ovarian cancer surgery, St James's University Hospital, Leeds, UK.
Marios Evangelos MamalisInformation Systems Lab, Department of Business Administration, University of Macedonia, Thessaloniki, Greece.ORCID 0009-0000-2680-0442
Michela QuarantaDepartment of Gynaecologic Oncology, ESGO Centre of Excellence for ovarian cancer surgery, St James's University Hospital, Leeds, UK.
Aishath ShaveeSchool of Medicine, University of Leeds, Leeds, UK.
Alina WahabSchool of Medicine, University of Leeds, Leeds, UK.
Amudha ThangaveluDepartment of Gynaecologic Oncology, ESGO Centre of Excellence for ovarian cancer surgery, St James's University Hospital, Leeds, UK.
Timothy BroadheadDepartment of Gynaecologic Oncology, ESGO Centre of Excellence for ovarian cancer surgery, St James's University Hospital, Leeds, UK.
David NugentDepartment of Gynaecologic Oncology, ESGO Centre of Excellence for ovarian cancer surgery, St James's University Hospital, Leeds, UK.
Evangelos KalampokisInformation Systems Lab, Department of Business Administration, University of Macedonia, Thessaloniki, Greece.
Alexandros LaiosDepartment of Gynaecologic Oncology, ESGO Centre of Excellence for ovarian cancer surgery, St James's University Hospital, Leeds, UK.ORCID 0000-0002-4870-7393

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCytoreductive surgery is critical for optimal tumor clearance in advanced epithelial ovarian cancer (EOC). Despite best efforts, some patients may experience R2 (>1 cm) resection, while others may not undergo surgery at all. We aimed to compare outcomes between advanced EOC patients undergoing R2 resection and those who had no surgery.

methodsRetrospective data from 51 patients with R2 resection were compared to 122 patients with no surgery between January 2015 and December 2019 at a UK tertiary referral centre. Progression-free survival (PFS) and overall survival (OS) were the study endpoints. Principal Component Analysis and Term Frequency - Inverse Document Frequency scores were utilized for data discrimination and prediction of R>2 cm from computed tomography pre-operative reports, respectively.

resultsNo statistical significance was observed, except for age (73 vs 67 years in the no- surgery vs R2 group,

conclusionsR2 resection and no-surgery cohorts displayed unfavourable prognosis with a notable degree of uniformity. When cytoreduction results in suboptimal results, the survival benefit may still be higher compared to those who underwent no surgery.

Indexed as

Carcinoma, Ovarian EpithelialCytoreduction Surgical ProceduresOvarian NeoplasmsAdultAgedFemaleHumansMiddle AgedProgression-Free SurvivalRetrospective Studiescytoreductionepithelial ovarian cancermachine learningnatural language processingprincipal component analysisprognosis estimationR2 resectionsurvival analysis

Identifiers

PMID39283489
PMCPMC11406603

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.